MedPath

Hyperopic LASIK With Crosslinking Versus Standard LASIK

Not Applicable
Completed
Conditions
Hyperopia
Interventions
Procedure: LASIK
Registration Number
NCT03224013
Lead Sponsor
Minia University
Brief Summary

Analysis corneal and refractive stability of hyperopic laser-assisted in situ keratomileusis (LASIK) with and without concurrent prophylactic high-fluence cross-linking (CXL).

Detailed Description

Interventional prospective consecutive comparative case control series of cases; 50 eyes of 25 patients with mean age 35.7 ± 12.4 (Range 18-61years) with hyperopia or hyperopic astigmatism underwent customized LASIK with concurrent prophylactic high-fluence cross-linking in right eye (group 1) and customized LASIK only in left eye (group 2). Cases with hyperopia +1 diopter to +6 diopters or hyperopic astigmatism up to 4 diopters were included in the study. Patients with previous intraocular or corneal surgery, active corneal disease were excluded from the study.

Main outcome measures were uncorrected visual acuity (UCVA), manifest refractive spherical equivalent (MRSE), cycloplegic refractive spherical equivalent (CRSE), keratometric measurements and spherical aberrations at 4 mm and maximum pupil and their evolution along 6 months postoperatively.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Cases with hyperopia +1diopter to +6 diopters or hyperopic astigmatism up to 4 diopters
Exclusion Criteria
  • Patients with previous intraocular or corneal surgery, active corneal disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hyperopic LASIK onlyLASIKgroup 2: hyperopic customized LASIK only
Hyperopic LASIK with crosslinkingLASIKgroup 1:hyperopic customized LASIK with concurrent prophylactic high-fluence cross-linking
Primary Outcome Measures
NameTimeMethod
assessment of changes in refractive spherical equivalentpreoperative and 3 months and 6 months postoperative

assessment of changes in manifest refraction by autorefractometer and then calculate spherical equivalent

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath